logo-large
  • Browse Categories

Publications by authors named "Richard F Porter"

Claim this Profile
S
Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
Richard Frederick Porter, Anna-Maria Szczesniak, James Thomas Toguri, Simon Gebremeskel, Brent Johnston

Molecules· September 2019


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.
Anna-Maria Szczesniak, Richard F Porter, James T Toguri, Joanna Borowska-Fielding, Simon Gebremeskel

Neuropharmacology· February 2017


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease.
Elizabeth A Cairns, J Thomas Toguri, Richard F Porter, Anna-Maria Szczesniak, Melanie E M Kelly

J Basic Clin Physiol Pharmacol· May 2016


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: